Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study

References

• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906.
   PubMed Web of Science ®Google Scholar
• Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018;36(12):1943–1952.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74–84.
   PubMed Web of Science ®Google Scholar
• Khene ZE, Peyronnet B, Kocher NJ, et al. Predicting morbidity after robotic partial nephrectomy: the effect of tumor, environment, and patient-related factors. Urol Oncol. 2018;36(7):338 e19-33–8 e26.
   PubMed Web of Science ®Google Scholar
• Tomaszewski JJ, Uzzo RG, Kutikov A, et al. Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status. Urology. 2014;83(4):843–849.
   PubMed Web of Science ®Google Scholar
• Kang HW, Kim SM, Kim WT, et al. The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma. J Cancer Res Clin Oncol. 2020;146(1):187–196.
   PubMed Web of Science ®Google Scholar
• Lund L, Jacobsen J, Norgaard M, et al. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study. J Urol. 2009;182(1):35–40.
   PubMed Web of Science ®Google Scholar
• Patel HD, Kates M, Pierorazio PM, et al. Comorbidities and causes of death in the management of localized T1a kidney cancer. Int J Urol. 2014;21(11):1086–1092.
   PubMed Web of Science ®Google Scholar
• Santos Arrontes D, Fernandez Acenero MJ, Garcia Gonzalez JI, et al. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol. 2008;179(3):857–861.
   PubMed Web of Science ®Google Scholar
• Gettman MT, Boelter CW, Cheville JC, et al. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol. 2003;169(4):1282–1286.
   PubMed Web of Science ®Google Scholar
• Berger DA, Megwalu II, Vlahiotis A, et al. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology. 2008;72(2):359–363.
   PubMed Web of Science ®Google Scholar
• Chen DY, Uzzo RG, Viterbo R. Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death. World J Urol. 2014;32(3):607–613.
   PubMed Web of Science ®Google Scholar
• Ather MH, Nazim SM. Impact of Charlson's comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma. Int Urol Nephrol. 2010;42(2):299–303.
   PubMed Web of Science ®Google Scholar
• Kutikov A, Egleston BL, Canter D, et al. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol. 2012;188(6):2077–2083.
   PubMed Web of Science ®Google Scholar
• Erlangsen A, Fedyszyn I. Danish nationwide registers for public health and health-related research. Scand J Public Health. 2015;43(4):333–339.
   PubMed Web of Science ®Google Scholar
• Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39(7 Suppl):72–74.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–33.
   PubMed Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229.
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish cancer registry. Scand J Public Health. 2011;39(7 Suppl):42–45.
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25.
   PubMed Web of Science ®Google Scholar
• Ewertz M, Christensen K, Engholm G, et al. Trends in cancer in the elderly population in Denmark, 1980-2012. Acta Oncol. 2016;55 Suppl 1:1–6.
   PubMed Web of Science ®Google Scholar
• Danckert B, Horsbol TA, Andersen O, et al. Registrations of patients with renal cell carcinoma in the nationwide Danish renal cancer database versus the Danish cancer registry: Data quality, completeness and survival (DaRenCa study-3). Clin Epidemiol. 2020;12:807–814.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus - Abbreviated Report of a WHO Consultation; 2011.
   Google Scholar
• Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–1530.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Försti A, Hemminki A, et al. Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden. PLOS One. 2021;16(6):e0253236.
   PubMed Web of Science ®Google Scholar
• Lv J, Song R, Cai H, et al. Outcomes of laparoscopic radical nephrectomy for elderly patients with localized renal cell carcinoma. J Buon. 2019;24(5):2147–2154. e0253236.
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Lohse CM, Cheville JC, et al. Predicting oncologic outcomes in renal cell carcinoma after surgery. Eur Urol. 2018;73(5):772–780.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
   PubMed Web of Science ®Google Scholar
• Sarfati D. Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol. 2012;65(9):924–933.
   PubMed Web of Science ®Google Scholar